Tumour lineage-homing cell-penetrating peptides as anticancer molecular delivery systems

Nature Communications

Volumn 3, Issue , 2012, Pages

  Kondo, Eisaku ^a,b   Saito, Ken ^a   Tashiro, Yuichi ^c   Kamide, Kaeko ^d   Uno, Shusei ^d   Furuya, Tomoko ^e   Mashita, Masao ^f   Nakajima, Kiichiro ^g   Tsumuraya, Tomoyuki ^h   Kobayashi, Naoya ⁱ   Nishibori, Masahiro ^j   Tanimoto, Mitsune ^j   Matsushita, Masayuki ^h  

^a AICHI CANCER CENTER HOSPITAL   (Japan)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c OKAYAMA UNIVERSITY   (Japan)

^d MITSUBISHI TANABE PHARMA CORPORATION   (Japan)

^e YAMAGUCHI UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^f Sigma Aldrich Japan Corporation   (Japan)

^g KNC Laboratories Co Ltd   (Japan)

^h UNIVERSITY OF THE RYUKYUS   (Japan)

ⁱ Okayama Saidaiji Hospital   (Japan)

^j OKAYAMA UNIVERSITY   (Japan)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CELL PENETRATING PEPTIDE; CPP44 P16; CPP44 RI P16MIS; CPP44 RI P16V95E; MESSENGER RNA; UNCLASSIFIED DRUG; SMALL INTERFERING RNA;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CASE REPORT; CELL LINEAGE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; EXPERIMENTAL MODEL; GROWTH INHIBITION; HEART METASTASIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VIVO STUDY; LUNG METASTASIS; MOUSE; NONHUMAN; PEPTIDE LIBRARY; TUMOR CELL; ANIMAL; CELL LINE; CHEMISTRY; DRUG SCREENING; FLOW CYTOMETRY; IMMUNOBLOTTING; METHODOLOGY; NEOPLASM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURFACE PLASMON RESONANCE; TUMOR CELL LINE;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE; CELL LINE, TUMOR; CELL-PENETRATING PEPTIDES; DRUG DELIVERY SYSTEMS; FLOW CYTOMETRY; HUMANS; IMMUNOBLOTTING; MICE; NEOPLASMS; PEPTIDE LIBRARY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; SURFACE PLASMON RESONANCE; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84864839075     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms1952     Document Type: Article

References (28)

1. Snyder, E. L. & Dowdy, S. F. Cell penetrating peptides in drug delivery. Pharm. Res. 21, 389-393 (2004). (Pubitemid 38338971)
2. Deshayes, S., Morris, M., Heitz, F. & Divita, G. Delivery of proteins and nucleic acids using a non-covalent peptide-based strategy. Adv. Drug Deliv. Rev. 60, 537-547 (2008). (Pubitemid 351222678)
3. Nagahara, H. et al. Transduction of full-length TAT fusion proteins into mammalian cells: TAT-p27Kip1 induces cell migration. Nat. Med. 4, 1449-1452 (1998). (Pubitemid 28553472)
4. Wadia, J. S. & Dowdy, S. F. Transmembrane delivery of protein and peptide drugs by TAT-mediated transduction in the treatment of cancer. Adv. Drug Deliv. Rev. 28, 579-596 (2005). (Pubitemid 40255562)
5. Roberts, R. W. Totally in vitro protein selection using mRNA-protein fusions and ribosome display. Curr. Opin. Chem. Biol. 3, 268-273 (1999). (Pubitemid 29248622)
6. Biyani, M., Husimi, Y. & Nemoto, N. Solid-phase translation and RNA-protein fusion: a novel approach for folding quality control and direct immobilization of proteins using anchored mRNA. Nucleic Acids Res. 34, E140 (2006).
7. Kamide, K., Nakakubo, H., Uno, S. & Fukamizu, A. Isolation of novel cell-penetrating peptides from a random peptide library using in vitro virus and their modifications. Int. J. Mol. Med. 25, 41-51 (2010).
8. Wender, P. A. et al. The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: peptoid molecular transporters. Proc. Natl Acad. Sci. USA 97, 13003-13008 (2000).
9. Yano, H. et al. Interferon alpha receptor expression and growth inhibition by interferon alfa in human liver cancer cell lines. Hepatology 29, 1708-1717 (1999). (Pubitemid 29247043)
10. Nakase, I. et al. Cellular uptake of arginine-rich peptides: roles for macropinocytosis and actin rearrangement. Mol. Ther. 10, 1011-1022 (2004). (Pubitemid 39625245)
11. Macia, E. et al. Dynasore, a cell-permeable inhibitor of dynamin. Dev. Cell 10, 839-850 (2006). (Pubitemid 43779110)
12. Marina-García, N. et al. Clathrin and Dynamin-dependent endocytic pathway regulates muramyl dipeptide internalization and NOD2 activation. J. Immunol. 182, 4321-4327 (2009).
13. Nakase, I. et al. Interaction of arginine-rich peptides with membrane-Associated proteoglycans is crucial for induction of actin organization and macropinocytosis. Biochemistry 16, 492-501 (2007). (Pubitemid 46105438)
14. Mayor, S. & Pagano, R. E. Pathways of clathrin-independent endocytosis. Nat. Rev. Mol. Cell Biol. 8, 603-612 (2007). (Pubitemid 47106613)
15. Gronlund, J. et al. Cloning of a novel scavenger receptor cysteine-rich type I transmembrane molecule (M160) expressed by human macrophages. J. Immunol. 165, 6406-6415 (2000).
16. Herman, J. G. et al. Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res. 55, 4525-4530 (1995).
17. Pinyol, M. et al. p16(INK4a) gene inactivation by deletions, mutations, and hypermethylation is associated with transformed and aggressive variants of non-Hodgkin's lymphomas. Blood 91, 2977-2984 (1998). (Pubitemid 28227549)
18. Goto, T. et al. Methylation of the p16 gene is frequently detected in lymphatic-invasive gastric cancer. Anticancer Res. 30, 2701-2703 (2010).
19. Fahraeus, R., Lain, S., Ball, K. L. & Lane, D. P. Characterization of the cyclin-dependent kinase inhibitory domain of the INK4 family as a model for a synthetic tumour suppressor molecule. Oncogene 16, 587-596 (1998). (Pubitemid 28062338)
20. Kondo, E., Seto, M., Yoshikawa, K. & Yoshino, T. Highly efficient delivery of p16 antitumor peptide into aggressive leukemia/lymphoma cells using a novel transporter system. Mol. Cancer Ther. 3, 1623-1630 (2004). (Pubitemid 40136718)
21. Kondo, E. et al. Potent synergy of dual antitumor peptides for growth suppression of human glioblastoma cell lines. Mol. Cancer Ther. 7, 1461-1471 (2008).
22. Gump, J. M. & Dowdy, S. F. TAT transduction: the molecular mechanism and therapeutic prospects. Trends Mol. Med. 13, 443-448 (2007). (Pubitemid 47562310)
23. Sloots, A. & Wels, W. S. Recombinant derivatives of the human high-mobility group protein HMGB2 mediate efficient nonviral gene delivery. FEBS J. 272, 4221-4236 (2005). (Pubitemid 41160928)
24. Gronlund, J., Vitved, L., Lausen, M., Skjodt, K. & Holmskov, U. Cloning of a novel scavenger receptor cysteine-rich type I transmembrane molecule (M160) expressed by human macrophages. J Immunol. 165, 6406-6415 (2000).
25. Law, S. K. et al. A new macrophage differentiation antigen which is a member of the scavenger receptor superfamily. Eur. J. Immunol. 23, 2320-2325 (1993). (Pubitemid 23265900)
26. Fink, J. R. & LeBien, T. W. Novel expression of cyclin-dependent kinase inhibitors in human B-cell precursors. Exp. Hematol. 29, 490-498 (2001). (Pubitemid 32297673)
27. Mizukami, Y. et al. Induction of interleukin-8 preserves the angiogenic response in HIF-1a-deficient colon cancer cells. Nat. Med. 11, 992-997 (2005). (Pubitemid 41294446)
28. Stanley, K. et al. Delta-like ligand 4-Notch blockade and tumor radiation response. J. Natl Cancer Inst. 103, 1778-1798 (2011).